FEATURES OF THE GASTRIC CANCER MICROENVIRONMENT IN OVERWEIGHT PATIENTS
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-22-3-2020-g.9037Keywords:
body mass index, gastric cancer, obesity, tumor microenvironmentAbstract
Obesity (Ob) increases the risk of malignant tumors development and worsens the course of the disease. The study of Ob in the oncological clinical practice requires the study of both adipose tissue and its impact on the tumor; so identifying factors of the tumor microenvironment associated with Ob will provide prospects for their use as markers of the tumor progression course in overweight patients. Objective: to identify the connection between different microenvironment parameters of gastric cancer (GC) (the rate of superoxide radicals (SR) generation, the hypoxia stages, the microvessels density (MVD), the activity of matrix metalloproteinases-2 and -9 (MMP-2 and -9), the number of tumor-associated macrophages (TAM), and tumor-infiltrating lymphocytes (TIL)) and the body mass index (BMI) of patients. Methods: clinical examination, EPR spectrometry, NMR spectroscopy, zymography in polyacrylamide gel, immunohistochemical, statistical. Results: in the tumor tissue of patients with gastric cancer and I–III degrees Ob, the level of SR generation was 2-times higher and the level of total gelatinase activity (MMP-2 and -9) was 1.4-times higher than in patients with normal body weight. The moderate and deep hypoxia of tumor tissue was observed more often among overweight (BMI > 25 kg/m2) gastric cancer patients than among normal weight (BMI < 25 kg/m2) patients. In the breast tissue of overweight patients (BMI > 25 kg/m2), the number of TAM was 1.4-times significantly higher and the level of TIL (T-lymphocytes) was 1.8-times significantly lower than in non-obese patients (BMI < 25 kg/m2). In tumors of middle-aged patients, there were found correlations between BMI and several indices: MVD, number of TAM and TIL (T-lymphocytes). Conclusion: the high values of BMI are associated with the increased pro-tumor characteristics of gastric cancer microenvironment, which indicates the influence of dysfunctional adipose tissue on tumor progression in the Ob and opens the possibility to study these factors of tumor microenvironment as markers of the gastric cancer course in overweight patients.
References
Hooper L, Abdelhamid A, Bunn D, et al. Effects of total fat intake on body weight. Cochrane Database Syst Rev 2015; 8: CD011834.
Mapping the health system response to childhood obesity in the WHO European Region. An overview and country perspectives (2019).
Nigro E, Scudiero O, Monaco ML, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed research international 2014; article ID 658913: 14.
Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen. Front endocrinol (lausanne) 2015; 6 (55): 1–5.
Colditz G, Peterson L. Obesity and cancer: evidence, impact, and future directions. Clinical Chemistry 2018; 64 (1):154–62.
Alexandre L, Long E, Beales L. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol 2014; 5 (4): 534–49.
Reaves DK, Ginsburg E, Bang JJ, et al. Persistent organic pollutants & obesity: potential mechanisms for breast cancer promotion? Endocr relat cancer 2015; 22 (2): 69–86.
Wu H, Ballantyne CM. Metabolic Inflammation and insulin resistance in obesity. Circulation Research 2020; 126: 1549–64.
Nurul M, Hussain AS, Sarwar S, et al. How the association between obesity and inflammation may lead to insulin resistance and cancer. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (2): 1213–24.
Bubnovskaya L, Osinsky D. Tumor microenvironment and metabolic factors: contribution to gastric cancer. Exp Oncol 2020; 42 (1): 2–10.
Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol 2017; 10: 36.
Carlomagno N, Incollingo P, Tammaro V, et al. Diagnostic, predictive, prognostic, and therapeutic molecular biomarkers in third millennium: a breakthrough in gastric cancer. Biomed Res Int 2017: ID7869802.
Chang WJ, Du Y, Zhao X. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20: 4586–96.
Bibak F, Ahmadi S, Khateri Z, Ahmadi A, et al. The role of matrix metalloproteinase-2 expression in gastric cancer susceptibility: a systematic review. Int J Cancer Manag 2019; 12 (9): e94185.
WHO Mean Body Mass Index (BMI). World Health Organization 2019, Retrieved 5.
Blackburn H, Jacobs D. Commentary: origins and evolution of body mass index (BMI): continuing saga. Int J Epidemiol 2014; 43 (3): 665–9.
Nuttall FQ. Body Mass Index Obesity, BMI, and Health. Nutrition Research 2015; 50 (3): 117–28.
De Clerk YA, Perez N, Shimada H. et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer research 1992; 52: 701–8.
Vaupel P, Okunieff P, Kallinowski F, et al. Correlation between 31P-NMR spectroscopy and tissue O2 tention measurements in a murine fibrocarcoma. Radiation Res 1989; 120: 477–93.
Burlaka AP, Sidorik EP, Ganusevich II, et al. High formation of superoxide anion and nitric oxide, and matrix metalloproteinases activity in vascular wall of rectal carcinoma vessels. Exp Oncol 2006; 28: 323–5.
Burlaka AA, Burlaka AP, Ganusevich II, Virko SV. Molecular mechanisms of oxidative damage and dysfunction of liver cells in patients with metastatic colorectal cancer. Exp Оncol 2019; 41 (4): 328–38.
Choi TG, Kim SS. Physiological functions of mitochondrial reactive oxygen species. Free Radical Medicine and Biology 2019; DOI: 10.5772/intechopen.88386.
Bonavida B. Nitric oxide and cancer: pathogenesis and therapy. Springer, 2015. 314 p.
Burlaka A, Ganusevich I, Gafurov M, et al. Stomach cancer: interconnection between the redox state, activity of MMP-2, MMP-9 and stage of tumor growth. Cancer Microenvironment 2016; 9: 27–32.
